Mechanisms for Lactobacillus rhamnosus treatment of intestinal infection by drug-resistant Escherichia coli

被引:2
|
作者
Li, Na [1 ]
Pang, Bing [1 ]
Li, Junjun [1 ]
Liu, Guanwen [1 ]
Xu, Xiaoguang [1 ]
Shao, Dongyan [1 ]
Jiang, Chunmei [1 ]
Yang, Baowei [2 ]
Shi, Junling [1 ]
机构
[1] Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, 127 Youyi West Rd, Xian 710072, Shaanxi, Peoples R China
[2] Coll Food Sci & Engn, 28 Xinong Rd, Yangling 712100, Shaanxi, Peoples R China
基金
国家重点研发计划;
关键词
LACTIC-ACID BACTERIA; CELL-SURFACE; ADHESION; BARRIER; PROBIOTICS; INTEGRITY; STRAINS; MYOSIN; MUCUS; GG;
D O I
10.1039/d0fo00128g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The development of probiotics as therapeutic drugs is greatly important for the protection against threats of drug-resistant pathogen infection in both humans and animals. This study showed that Lactobacillus rhamnosus SHA113, previously isolated from breast milk of healthy humans, showed efficient therapeutic effects on infection by drug resistant Escherichia coli QBQ009. In addition to protecting the intestinal barrier via up-regulating the expression of tight junction proteins ZO-1 and occludin, it was also found that (1) both L. rhamnosus SHA113 and E. coli QBQ009 cells caused changes of the epithelial cell cytoskeleton and up-regulated the expression of phagocytosis-related proteins MYH2 in Caco-2 cells; however, only E. coli QBQ009 caused a strong decrease of cell viability. L. rhamnosus SHA113 treatment after E. coli QBQ009 infection significantly restored the damaged intestinal barrier and the changes of the epithelial cell cytoskeleton caused by E. coli QBQ009. (2) L. rhamnosus SHA113 showed a much higher adhesion rate to the intestinal tract and Caco-2 cells than E. coli QBQ009. The presence of E. coli QBQ009 significantly decreased the adhesion rate of L. rhamnosus SHA113, but not in reverse. (3) L. rhamnosus SHA113 had much higher self-coagulation than E. coli, and could strongly co-coagulate with E. coli QBQ009. The viability of E. coli QBQ009 greatly decreased after co-coagulation, while that of L. rhamnosus SHA113 was not influenced. (4) The polysaccharides produced by L. rhamnosus SHA113 significantly decreased the permeability of the intestinal tract and Caco2 cells, but had no remarkable influence on the adhesion rate of E. coli QBQ009. (5) Feeding L. rhamnosus SHA113 caused a significant reduction of Proteobacteria in the cecum of healthy mice, which was not significant in infected and treated mice. In summary, the decreased live pathogen amounts might be one of the decisive factors for the efficient cure of E. coli QBQ009 infection by L. rhamnosus SHA113, and the restoration of the intestinal barrier might be caused by the reduction of pathogens.
引用
收藏
页码:4428 / 4445
页数:18
相关论文
共 50 条
  • [1] The effect of Lactobacillus rhamnosus on enterohemorrhagic Escherichia coli infection of human intestinal cells in vitro
    Hirano, J
    Yoshida, T
    Sugiyama, T
    Koide, N
    Mori, I
    Yokochi, T
    MICROBIOLOGY AND IMMUNOLOGY, 2003, 47 (06) : 405 - 409
  • [2] Effect of Lactobacillus plantarum on Intestinal Infection in Multiple Drug-Resistant Bacteria Mice
    Han, Hua-Zhong
    Zhao, Yi-Jun
    Shi, Chen-Zhang
    Liang, Yong
    Yang, Jun
    SURGICAL INFECTIONS, 2015, 16 (06) : 762 - 768
  • [3] Drug-resistant Escherichia coli, rural Idaho
    Hannah, EL
    Angulo, FJ
    Johnson, JR
    Haddadin, B
    Williamson, J
    Samore, MH
    EMERGING INFECTIOUS DISEASES, 2005, 11 (10) : 1614 - 1617
  • [4] Drug-resistant diarrheogenic Escherichia coli, Mexico
    Estrada-García, T
    Cerna, JF
    Paheco-Gil, L
    Velázquez, RF
    Ochoa, TJ
    Torres, J
    DuPont, HL
    EMERGING INFECTIOUS DISEASES, 2005, 11 (08) : 1306 - 1308
  • [5] Enhanced competitiveness of drug-resistant Escherichia coli
    McDermott, PJ
    Smith, LH
    Gowland, P
    Gowland, PC
    NATIONAL ACADEMY SCIENCE LETTERS-INDIA, 1999, 22 (3-4): : 41 - 45
  • [6] THE PERSISTENCE OF DRUG-RESISTANT ESCHERICHIA-COLI IN THE INTESTINAL FLORA OF HEALTHY BROILER CHICKS
    HINTON, M
    ALCHALABY, ZAM
    ALLEN, V
    LINTON, AH
    JOURNAL OF HYGIENE, 1982, 89 (02) : 269 - 278
  • [7] DRUG-RESISTANT AND BIOACTIVE ESCHERICHIA-COLI IN BEIJING
    ARAI, T
    KOMATSU, S
    ULLAH, MA
    CHINESE MEDICAL JOURNAL, 1984, 97 (11) : 819 - 824
  • [8] Risk factors for urinary tract infection with multiple drug-resistant Escherichia coli in cats
    Hernandez, Juan
    Bota, Doroteia
    Farbos, Marion
    Bernardin, Fanny
    Ragetly, Guillaume
    Medaille, Christine
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2014, 16 (02) : 75 - 81
  • [9] Treatment of drug-resistant Aspergillus infection
    Aigner, Maria
    Lass-Floerl, Cornelia
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (15) : 2267 - 2270
  • [10] Lactobacillus rhamnosus from human breast milk shows therapeutic function against foodborne infection by multi-drug resistant Escherichia coli in mice
    Li, Na
    Pang, Bing
    Liu, Guanwen
    Zhao, Xixi
    Xu, Xiaoguang
    Jiang, Chunmei
    Yang, Baowei
    Liu, Yanlin
    Shi, Junling
    FOOD & FUNCTION, 2020, 11 (01) : 435 - 447